Clinical Trial Update: Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating linaclotide for opioid-induced constipation in patients on chronic opioid therapy for non-cancer pain has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cancer Pain
• Opioid-induced Constipation

Drugs mentioned

• Linaclotide (linaclotide)

Snippet

Sponsor: Forest Laboratories | Conditions: Opioid-Induced Constipation | Phase 2 | Status: COMPLETED | Results posted: 2019-04-08